Lipids - Poster discussant:

9 More presentations in this session

Improvement of lipid profile post cardiac rehabilitation according to the patient's level of risk in a tertiary hospital

Doctor A. Chauca Tapia (Barcelona, ES)

Efficacy of the PCSK9 inhibitors evolocumab/alirozumab in the reduction of LDL and Lp (a) in patients with familial hypercholesterolemia/manifest atherosclerosis in a real world setting

Mr M. Poudel (Bielefeld, DE)

Abstract Slides

Anti-PCSK9 in everyday clinical practice

Doctor R. Cadenas Chamorro (Madrid, ES)

Abstract Slides

Evaluation of LDL cholesterol level in patients with coronary artery disese after cardiac rehabilitation

Professor N. Mouine (Rabat, MA)

Abstract Slides

Safety aspects and side effects of the novel lipid-lowering PCSK9 inhibitors evolocumab /alirozumab in atherosclerotic patients with familial hypercholesterolemia under lipid apheresis

Mr M. Poudel (Bielefeld, DE)

Abstract Slides